Drug Type Small molecule drug |
Synonyms 2-(Methoxycarbonyl)phenol, 2-Carbomethoxyphenol, 2-Hydroxybenzoic acid methyl ester + [15] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Jan 1974) |
Regulation- |
Molecular FormulaC8H8O3 |
InChIKeyOSWPMRLSEDHDFF-UHFFFAOYSA-N |
CAS Registry119-36-8 |
Start Date30 Jul 2026 |
Sponsor / Collaborator |
Start Date30 Jun 2023 |
Sponsor / Collaborator- |
Start Date15 May 2023 |
Sponsor / Collaborator- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01087 | Methyl Salicylate |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Pain | China | 01 Jan 1992 |
| Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
|---|
Phase 2 | 96 | dilbjwjckk = mdynyomhux wurmlnxpsg (zzoidauapo, ydptloehiy - crthaidzdg) View more | - | 17 Aug 2026 | |||
Not Applicable | - | (Peppermint essential oil) | tjsqxcozcc(cnpeipxdwv) = kuyoomzuhq yahigfbzin (nyohjvalpu ) View more | - | 01 Feb 2023 | ||
(Ginger essential oil) | tjsqxcozcc(cnpeipxdwv) = plxnfmrter yahigfbzin (nyohjvalpu ) View more |







